Pfizer announced today that a COVID-19 vaccine that they have been developing in collaboration with BioNTech was found in a Phase 3, late-stage study “to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.”
Pfizer’s CEO went on CNBC and said that over a billion doses will be available in 2021:
Pfizer CEO Albert Bourla says he would like to be among the first to take his company's coronavirus vaccine to ease concerns about safety. Bourla says Pfizer is on track to produce up to 50 million vaccine doses in 2020, and up to 1.3 billion doses in 2021.https://t.co/3sgGcv0CES pic.twitter.com/0jcYvTewaj
— CNBC (@CNBC) November 9, 2020
Unsurprisingly, stock futures (except for companies that benefit from lockdowns, like Zoom, which is down about 12% pre-market), are up big today. S&P futures are up over 4%, and Dow futures are up nearly 6%.
This is some great news that, hopefully, the world will be approaching a normal place by next summer.